Overview: KIM-1 TestIntroduction: The KIM-1 Test measures KIM-1 levels to assess kidney injury, helping diagnose kidney disease causing swelling or reduced urine output. Affecting 1 in 1,000 people with kidney injury, KIM-1 elevation poses diagnostic challenges due to early detection needs. Following 2023 National Kidney Foundation (NKF) guidelines, it uses ELISA for high accuracy, supporting biochemistry screening. This test is vital for diagnosis, monitoring, and improving outcomes in nephrology.
Other Names: Kidney Injury Molecule-1 Test, KIM-1 Assay.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic reliability.
Historical Milestone: KIM-1 testing began in the 2000s with research by Bonventre, who linked it to kidney injury. ELISA advancements by R&D Systems improved detection, surpassing earlier Western blot methods.
Purpose: Measures KIM-1 levels to diagnose kidney injury, guides treatment or monitoring, and evaluates patients with swelling, aiming to prevent damage.
Test Parameters: KIM-1 levels
Pretest Condition: No special preparation required. Collect urine. Report history of kidney issues.
Specimen: Urine (sterile container, 5-20 mL); 10 mL urine in sterile container. Transport in a biohazard container.
Sample Stability at Room Temperature: 4 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: 1 month
Medical History: Document swelling or reduced urine output. Include current medications or family history.
Consent: Written consent required, detailing the test's purpose, disease risks (e.g., renal failure), and sample collection risks.
Procedural Considerations: Uses ELISA to measure KIM-1, requiring labs with plate readers. Results available in 2-3 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample degradation or contamination can affect results. Medications may alter levels, requiring correlation.
Clinical Significance: Elevated KIM-1 confirms kidney injury, guiding therapy. Early intervention might prevent progression, while untreated cases lead to failure. Normal levels may require creatinine tests.
Specialist Consultation: Consult a nephrologist for interpretation.
Additional Supporting Tests: Urinalysis, creatinine, or imaging to confirm diagnosis.
Test Limitations: Non-specific for cause; correlation with symptoms needed. False negatives possible with early injury.
References: NKF Guidelines, 2023; Journal of the American Society of Nephrology, Bonventre JV, 2022.
